CIK 0001124524
- Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 880313393
- Phone
- +1 949-232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-15 | BADDOUR LINDA Director | Option exercise · Restricted Stock Rights | −1,111 | 2,222 | ||
| 2022-03-14 | Sawicki Mark W Chief Scientific Officer | Grant or award | +10,455 | 61,841 | ||
| 2022-03-14 | Sawicki Mark W Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +20,910 | 20,910 | ||
| 2022-03-14 | SHELTON JERRELL Chief Executive Officer | Grant or award | +27,092 | 431,136 | ||
| 2022-03-14 | SHELTON JERRELL Chief Executive Officer | Grant or award · Stock Option (right to buy) | +60,952 | 60,952 | ||
| 2022-03-14 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award | +10,455 | 96,256 | ||
| 2022-03-14 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award · Stock Option (right to buy) | +20,910 | 20,910 | ||
| 2022-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +2,667 | 86,896 | ||
| 2022-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −1,095 | $31.05 | $34K | 85,801 |
| 2022-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Restricted Stock Rights | −2,667 | 8,000 | ||
| 2022-03-09 | SHELTON JERRELL Chief Executive Officer | Option exercise | +8,250 | 407,342 | ||
| 2022-03-09 | SHELTON JERRELL Chief Executive Officer | Sale | −3,298 | $31.05 | $102K | 404,044 |
| 2022-03-09 | SHELTON JERRELL Chief Executive Officer | Option exercise · Restricted Stock Rights | −8,250 | 24,750 | ||
| 2022-03-09 | Sawicki Mark W Chief Scientific Officer | Option exercise | +2,667 | 52,796 | ||
| 2022-03-09 | Sawicki Mark W Chief Scientific Officer | Sale | −1,410 | $31.05 | $44K | 51,386 |
| 2022-03-09 | Sawicki Mark W Chief Scientific Officer | Option exercise · Restricted Stock Rights | −2,667 | 8,000 | ||
| 2022-01-27 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +47,812 | $1.87 | $89K | 79,229 |
| 2022-01-27 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +5,000 | $5.16 | $26K | 84,229 |
| 2022-01-27 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Options to purchase common stock | −47,812 | 0 | ||
| 2022-01-27 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Options to purchase common stock | −5,000 | 0 |
Page 15 of 28 · 541 trades